Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation

Clinical trial NCT06127355 · COMPLETED

Trial details

NCT number: NCT06127355
Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gestational Diabetes

Start date: 2021-03-03
Primary completion: 2022-02-09
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.